Andrew Teodorczuk1, Brett Emmerson2, Gail Robinson3. 1. School of Medicine, Gold Coast Campus, Griffith University, Southport, QLD, and; The Prince Charles Hospital, Metro North Mental Health, Brisbane, QLD Australia. 2. The Prince Charles Hospital, Metro North Mental Health, Brisbane, QLD, and; School of Clinical Medicine, University of Queensland, Brisbane, QLD, Australia. 3. The Prince Charles Hospital, Metro North Mental Health, Brisbane, QLD, and; Menzies Health Institute, Griffith University Campus, Nathan, QLD, Australia.
Abstract
OBJECTIVE: The purpose of this opinion article is to review the recent evidence base in relation to the role of electroconvulsive therapy (ECT) in the management of patients with schizophrenia. Specifically, we explore the efficacy and safety of ECT. Furthermore, consideration is given to the profile of patients who benefit most from ECT, the role of maintenance ECT and what happens when ECT is not given. CONCLUSION: Our brief review of the evidence suggests that clinical practice in developing countries has not kept up with the growing literature supporting ECT use in schizophrenia. As such, we advocate that ECT should not be a treatment of last resort. Rather, it should be considered more readily as an add-on therapy when there has been a poor response to antipsychotic medications or concerns exist about side effects. Further research is needed into the efficacy of maintenance ECT.
OBJECTIVE: The purpose of this opinion article is to review the recent evidence base in relation to the role of electroconvulsive therapy (ECT) in the management of patients with schizophrenia. Specifically, we explore the efficacy and safety of ECT. Furthermore, consideration is given to the profile of patients who benefit most from ECT, the role of maintenance ECT and what happens when ECT is not given. CONCLUSION: Our brief review of the evidence suggests that clinical practice in developing countries has not kept up with the growing literature supporting ECT use in schizophrenia. As such, we advocate that ECT should not be a treatment of last resort. Rather, it should be considered more readily as an add-on therapy when there has been a poor response to antipsychotic medications or concerns exist about side effects. Further research is needed into the efficacy of maintenance ECT.